Literature DB >> 15094068

Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface.

Geert Jan Biessels, Bert Bravenboer, Willem Hendrik Gispen.   

Abstract

The brain has long been viewed as an insulin-insensitive organ. Following the demonstration of insulin receptors in the brain, this assumption has been challenged, and a whole new field of research has emerged. Insulin appears to play a role in brain physiology, and disturbances of cerebral insulin signalling and glucose homeostasis are implicated in brain pathology. This special issue of the European Journal of Pharmacology provides an overview of research into the involvement of glucose and insulin in the modulation of cognition and synaptic plasticity in health and in disease. In three sections, the effects of glucose and insulin on the brain will be discussed from a physiological perspective, in relation to brain ageing and Alzheimer's disease, and in relation to diabetes mellitus, respectively. These subjects will be covered from various angles, from the level of molecular neurosciences, to the level of applied neuropsychology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094068     DOI: 10.1016/j.ejphar.2004.02.057

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 2.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

Review 3.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

4.  Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Authors:  Mohammad A Kamal; Shazi Shakil; Muhammad S Nawaz; Qian-Sheng Yu; David Tweedie; Y Tan; Xianqin Qu; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2017       Impact factor: 4.388

5.  Screening for cognitive impairment in older adults attending an eye clinic.

Authors:  Mukaila A Raji; Rosa A Tang; Patricia C Heyn; Yong-Fang Kuo; Steven V Owen; Sonali Singh; Kenneth J Ottenbacher
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

6.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits.

Authors:  Celine Ullrich; Michael Pirchl; Christian Humpel
Journal:  Mol Cell Neurosci       Date:  2010-08-06       Impact factor: 4.314

9.  Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism.

Authors:  P K Thanos; M Michaelides; J-D Gispert; J Pascau; M L Soto-Montenegro; M Desco; R Wang; G-J Wang; N D Volkow
Journal:  Int J Obes (Lond)       Date:  2008-05-13       Impact factor: 5.095

Review 10.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.